Related Experiment Video
Updated: Mar 22, 2026

Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
Published on: April 1, 2018
Separating the wheat from the chaff: systematic identification of functionally relevant noncoding variants in ADHD.
J H S Tong1, Z Hawi1, C Dark1
1School of Psychological Sciences and Monash Institute for Cognitive and Clinical Neurosciences, Monash University, Melbourne, VIC, Australia.
Identifying genetic risk for attention deficit hyperactivity disorder (ADHD) is key. This study prioritizes noncoding DNA variants, finding 65 with functional annotations for future ADHD research and treatment development.
Area of Science:
- Genetics
- Neurobiology
- Bioinformatics
Background:
- Attention deficit hyperactivity disorder (ADHD) is a highly heritable psychiatric condition with significant negative lifetime impacts.
- Understanding the genetic architecture of ADHD is crucial for neurobiological insights and developing novel treatments.
- Previous research identified numerous potential genetic association signals, necessitating methods to distinguish true associations from false ones.
Purpose of the Study:
- To identify and prioritize functionally relevant DNA variants associated with ADHD.
- To develop a tractable shortlist of variants for experimental validation in ADHD research.
- To highlight the importance of noncoding variants in ADHD genetic risk and propose a bioinformatics approach for psychiatric disorders.
Main Methods:
- Defined a set of 2070 DNA variants associated with ADHD or in linkage disequilibrium.
- Utilized genome-wide annotation tools (GWAVA, CADD) to prioritize noncoding variants based on pathogenicity.
- Leveraged large-scale genomic datasets (ENCODE, NIH Roadmap) to assign functional annotations to prioritized variants.
Main Results:
- Over 97% of the 2070 identified variants were noncoding.
- Identified 65 variants with high likelihood of pathogenicity and assigned functional annotations (e.g., impact on splicing, transcription factor binding, translational regulation).
- These 65 variants represent a promising shortlist for future experimental validation in ADHD.
Conclusions:
- Noncoding variants play a significant role in the genetic risk of ADHD.
- The study presents a robust bioinformatics approach for prioritizing functional variants in psychiatric disorders.
- The identified 65 variants offer clear hypotheses for experimental investigation into ADHD's genetic underpinnings and potential therapeutic targets.
More Related Videos
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
Published on: August 21, 2016
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Pharmacogenomics: Identification of New Drug Targets